USPTO serial 79409996
CARMS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 4, 2025
- Examiner
- GARDNER, DAWNA BERYL
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CARMS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sarah Matthews
Sarah Matthews DENTONS DURHAM JONES PINEGAR1557 W. Innovation Way, STE 400Lehi, UT 84043United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; scientific apparatus and instruments, namely, fluid handling device used for disposable bioprocessing applications and parts and fitting therefor; apparatus for scientific research in laboratories, namely, scientific laboratory instruments for detecting pathogens; scientific, research and laboratory apparatus, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection or counting; laboratory apparatus and instruments, namely, medical laboratory research instruments for thermal imaging; instruments for scientific research in laboratories, namely, laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; laboratory instruments for scientific research, namely, scientific laboratory instruments for detecting pathogens; scientific instruments, namely, electronic analyzers for measuring, testing and detecting contaminants and environmental pollutants; scientific apparatus, namely, optical mirrors; apparatus and instruments for research use, namely, scientific laboratory instruments for detecting pathogens; laboratory apparatus and instruments for scientific research, namely, scientific laboratory instruments for detecting pathogens; research apparatus and instruments, namely, medical laboratory research instruments for thermal imaging; apparatus and instruments for research purposes, namely scientific laboratory instruments for detecting pathogens | ACTIVE | — |
| 010 | Medical instruments, namely, diagnostic apparatus for analyzing and testing cell cultures and organoids; medical instruments for analyzing and testing bacteria. | ACTIVE | — |
| 042 | Scientific research services in the field of bacteriology, namely, isolation and cultivation of bacterial cells; pharmaceutical research services; scientific research relating to molecular sciences; medical research and development in the field of molecular biology; medical research services; medical research laboratory services; biomedical research services; research in the field of science; testing of human tissues and stem cells for scientific research purposes; analysis of human tissues and stem cells for scientific research purposes; scientific research and analysis in the field of biological research and analysis; scientific research for medical purposes; scientific research and analysis services, namely, biological research and analysis; advisory services relating to scientific research; scientific research; pharmaceutical drug development services; drug discovery services; pharmaceutical research and development; pharmaceutical research and development, namely, development of pharmaceuticals; pharmaceutical research and development, namely, development of pharmaceutical preparations and medicines; scientific research and development for the pharmaceutical industry; scientific research and development; scientific and medical research and development; research to develop new products; conducting early evaluations in the field of new pharmaceuticals; research and development services of new pharmaceutical products; research in the field of pharmaceuticals; scientific research and development services for the pharmaceutical industry; biochemical research and development; laboratory research in the field of pharmaceuticals; scientific research in the field of pharmacogenomics; research and development services in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about medical and scientific research in the field of pharmaceuticals; product development consultancy for inventors in the field of molecular biology; research and development in the field of biochemistry * ; all the above-mentioned services exclude services related to scientific research in the field of climate change, climate action, equity, sustainability, economic diversification and energy system transition, climate action management * | ACTIVE | — |
| 044 | Medical analysis services for the diagnosis and treatment of persons; pharmaceutical advice; providing information relating to drugs, namely, providing information relating to diagnostic, prophylactic and therapeutic property of pharmaceuticals; advisory services relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MassAffinity Pty Limited
- Other trademarks owned by MassAffinity Pty Limited
- Other trademarks owned by MassAffinity Pty Limited
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CARMS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jun 4, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 18, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 18, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 18, 2026 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| May 16, 2026 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 16, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 7, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 20, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 4, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 4, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 4, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 16, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 16, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 17, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 12, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 12, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 12, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 2, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 15, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 29, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 29, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 29, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 28, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 21, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |